HTR4 and irritable bowel syndrome: Since cisapride is now known to cause cardiac rhythm disturbances [12], a new prokinetic agent, tegaserod, a partial 5-HT4-agonist [13], which enhances peristalsis, was approved for the treatment of patients exhibiting symptomatic irritable bowel syndrome (IBS) with constipation.